{"publication_id":"49395fbb-d4a2-4334-b9a8-44b8df0e7129","method_note":"Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.","sources":[{"study":"Sodium‐Glucose Cotransporter‐2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Population‐Based Investigation","doi":"10.1161/jaha.122.027824","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis","doi":"10.1186/s12933-022-01455-2","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Trials","doi":"10.1161/jaha.120.019463","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies","doi":"10.1016/j.phrs.2021.105836","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis","doi":"10.1093/eurjpc/zwab173","risk_of_bias":"not appraised in public sidecar","directness":"review-level"}]}